Press Releases

FDB (First Databank) continues to operate its business and all of its software solutions as normal.

The Multilex drug database includes records for the available COVID-19 vaccines in the UK (including the COVID-19 mRNA vaccine BNT162B2 manufactured by Pfizer- BioNTech) in line with the NHS BSA Dictionary of Medicines and Devices.

FDB (First Databank) is pleased to announce that their latest medicines optimisation solution, FDB AnalyseRx, has been approved to join the G-Cloud 12 framework, joining FDB OptimiseRx on the government’s latest G-Cloud framework.

Norfolk and Waveney Clinical Commissioning Group to support prescribers to improve the quality and safety of prescribing

University of Nottingham team and FDB partner to flag crucial national safety indicators to thousands of primary care professionals through OptimiseRx prescribing software

FDB today announced that it will be exhibiting at Digital Health Rewired 2020 on 4th March at London Olympia

Charles Tuchinda Named Executive Chairman and Bob Katter Promoted to President

FDB has announced that it has completed content development to improve coverage of lymphoedema appliances, specifically around the addition of dm+d lymphoedema items within the FDB Multilex database.

Calls for GP practices to standardise routine drug therapeutic monitoring after disparity revealed in analysis of practice data from FDB’s OptimiseRx

York Teaching Hospital NHS Foundation Trust was shortlisted for a BBH Award - Best Use of Technology (Acute Care).

Darren Nichols, Managing Director at FDB UK, comments on the findings and recommendations from Public Health England’s review into dependence and withdrawal associated with some prescribed medicines

Refreshed global brand marks the company’s fourth decade of continuous business operations.

GP practices and NHS clinical commissioning groups across England save over £100 million since using FDB OptimiseRx to improve prescribing quality.